Daniel Len Edmonston, MD

Medical Instructor in the Department of Medicine
Member in the Duke Clinical Research Institute
Email address daniel.edmonston@duke.edu

My primary research focus lies at the intersection of kidney and cardiovascular disease including pulmonary hypertension, heart failure, and atherosclerotic disease in patients with chronic kidney disease. 

Education and Training

  • Fellowship, Nephrology, Duke University, 2016 - 2019
  • Residency, Medicine, New York Presbyterian Hospital, 2013 - 2016
  • M.D., Mercer University, School of Medicine, 2013

Publications

South, Andrew M., Laurie Tomlinson, Daniel Edmonston, Swapnil Hiremath, and Matthew A. Sparks. “Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.” Nat Rev Nephrol 16, no. 6 (June 2020): 305–7. https://doi.org/10.1038/s41581-020-0279-4.

PMID
32246101
Full Text

Edmonston, Daniel L., Kishan S. Parikh, Sudarshan Rajagopal, Linda K. Shaw, Dennis Abraham, Alexander Grabner, Matthew A. Sparks, and Myles Wolf. “Pulmonary Hypertension Subtypes and Mortality in CKD.” Am J Kidney Dis 75, no. 5 (May 2020): 713–24. https://doi.org/10.1053/j.ajkd.2019.08.027.

PMID
31732231
Full Text

Edmonston, Daniel, Daniel Wojdyla, Rupal Mehta, Xuan Cai, Claudia Lora, Debbie Cohen, Raymond R. Townsend, et al. “Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.” Am J Kidney Dis 74, no. 6 (December 2019): 771–81. https://doi.org/10.1053/j.ajkd.2019.05.026.

PMID
31445926
Full Text

Edmonston, Daniel L., Christina M. Wyatt, and Sana M. Al-Khatib. “Atrial fibrillation and kidney disease: stuck outside the CABANA.” Kidney Int 96, no. 5 (November 2019): 1054–55. https://doi.org/10.1016/j.kint.2019.05.023.

PMID
31443996
Full Text

Edmonston, Daniel L., Jingjing Wu, Roland A. Matsouaka, Clyde Yancy, Paul Heidenreich, Ileana L. Piña, Adrian Hernandez, Gregg C. Fonarow, and Adam D. DeVore. “Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients.” Am Heart J 212 (June 2019): 101–12. https://doi.org/10.1016/j.ahj.2019.03.005.

PMID
30978555
Full Text

Hein, Aaron M., Julia J. Scialla, Daniel Edmonston, Lauren B. Cooper, Adam D. DeVore, and Robert J. Mentz. “Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.” Jacc Heart Fail 7, no. 5 (May 2019): 371–82. https://doi.org/10.1016/j.jchf.2019.02.009.

PMID
31047016
Full Text

McHugh, Kelly R., Adam D. DeVore, Robert J. Mentz, Daniel Edmonston, Jennifer B. Green, and Adrian F. Hernandez. “The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes.” Clin Cardiol 41, no. 9 (September 2018): 1259–67. https://doi.org/10.1002/clc.23054.

PMID
30125365
Full Text

Pages